Endocrine tumor and intraductal papillary mucinous neoplasm of the pancreas: A fortuitous association?

被引:39
作者
Marrache, F
Cazals-Hatem, D
Kianmanesh, R
Palazzo, L
Couvelard, A
O'Toole, D
Maire, F
Hammel, P
Levy, P
Sauvanet, A
Ruszniewski, P
机构
[1] AP HP, Hop Beaujon, Serv Gastroenterol, Federat Medicochirurg Hepatogastroenterol, F-92118 Clichy, France
[2] AP HP, Hop Beaujon, Serv Anat & Cytol Pathol, F-92118 Clichy, France
[3] AP HP, Hop Beaujon, Serv Chirurg Digest, Federat Medicochirurg Hepatogastroenterol, F-92118 Clichy, France
关键词
intraductal papillary mucinous neoplasm; pancreatic endocrine tumors; pancreatic neoplasia;
D O I
10.1097/01.mpa.0000164453.46394.07
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: Pancreatic endocrine tumors (PETs) and intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are rare diseases of the pancreas. Cases of association of endocrine and exocrine neoplasms of the pancreas have been reported, corresponding to mixed or amphicrine tumors. The aim of this report is to describe a series of 6 patients with an original association of IPMN and PET of the pancreas. Methods: Among 108 and 103 patients operated on in our center between January 1997 and December 2003 for PETs and IPMNs, respectively, we identified 6 patients with both PET and IPMN, diagnosed on pathologic examination with an immunohistochemical study. Results: Preoperative diagnosis was unspecified pancreatic tumor (n = 1), IPMN (n = 2), and association of PET and IPMN (n = 3). IPMN involved the main pancreatic duct in 4 patients and was classified as benign (n = 4), borderline (n = 1), or malignant noninvasive (n = 1). PETs measured 1.1 to 3 cm and were malignant in 1 patient (lymph node invasion). When analyzed by immunohistochemistry, 2 cases expressed glucagon, 1 expressed somatostatin, and 1 expressed insulin. Conclusion: This study describes a new aspect of endocrine-exocrine pancreatic neoplasm association. The frequency of the association of PET and IPMN is too large to be fortuitous. Further studies are needed to understand its mechanism.
引用
收藏
页码:79 / 83
页数:5
相关论文
共 26 条
  • [1] [Anonymous], 2000, WHO Classification of Tumors of the Digestive System
  • [2] Pancreatic cancer biology and genetics
    Bardeesy, N
    DePinho, RA
    [J]. NATURE REVIEWS CANCER, 2002, 2 (12) : 897 - 909
  • [3] Antiproliferative effect of somatostatin and analogs
    Bousquet, C
    Puente, E
    Buscail, L
    Vaysse, N
    Susini, C
    [J]. CHEMOTHERAPY, 2001, 47 : 30 - 39
  • [4] Expression and processing of gastrin in pancreatic adenocarcinoma
    Caplin, M
    Savage, K
    Khan, K
    Brett, B
    Rode, J
    Varro, A
    Dhillon, A
    [J]. BRITISH JOURNAL OF SURGERY, 2000, 87 (08) : 1035 - 1040
  • [5] Goetze JP, 2000, CANCER, V88, P2487, DOI 10.1002/1097-0142(20000601)88:11<2487::AID-CNCR9>3.0.CO
  • [6] 2-E
  • [7] Ductal and acinar differentiation in pancreatic endocrine tumors
    Kamisawa, T
    Tu, Y
    Egawa, N
    Ishiwata, JI
    Tsuruta, K
    Okamoto, A
    Hayashi, Y
    Koike, M
    Yamaguchi, T
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (10) : 2254 - 2261
  • [8] CLINICAL PATHOLOGY OF ENDOCRINE TUMORS OF THE PANCREAS - ANALYSIS OF AUTOPSY CASES
    KIMURA, W
    KURODA, A
    MORIOKA, Y
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1991, 36 (07) : 933 - 942
  • [9] MIXED ACINAR-ENDOCRINE CARCINOMAS OF THE PANCREAS
    KLIMSTRA, DS
    ROSAI, J
    HEFFESS, CS
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1994, 18 (08) : 765 - 778
  • [10] Kloppel G, 2000, World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System, P221